NCT06560476View on ClinicalTrials.gov

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

March 30, 2027

Study Completion Date

March 30, 2027

Conditions
Benign Prostatic Hyperplasia
Interventions
OTHER

Data collection

Subject's data will be collected from patients that are undergoing care using the Optilume drug-coated catheter system.

Trial Locations (8)

11791

RECRUITING

Northwell Health - Smith Institute of Urology, Syosset

22191

RECRUITING

Potomac Urology, Woodridge

33615

RECRUITING

Florida Urology Partners, Tampa

68144

RECRUITING

Adult & Pediatric Urology, PC, Omaha

68847

RECRUITING

Kearney Urology Center, Kearney

89144

RECRUITING

Sheldon Freedman, Ltd, Las Vegas

95823

RECRUITING

Golden State Urology, Sacramento

97330

RECRUITING

Good Samaritan Hospital, Corvallis

All Listed Sponsors
lead

Urotronic Inc.

INDUSTRY

NCT06560476 - OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH | Biotech Hunter | Biotech Hunter